EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
38 hedge funds and large institutions have $84.5M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GCL
Glazer Capital LLC
New York
|
+$6.98M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$3.75M |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$562K |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$388K |
| 5 |
MSU
Mizuho Securities USA
New York
|
+$192K |
